The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A dose-finding study of the SMAC mimetic Debio 1143 when given in combination with avelumab to patients with advanced solid malignancies.
 
Rosalyn A. Juergens
Honoraria - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis Canada Pharmaceuticals Inc; Roche Canada
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; Fusion Pharmaceuticals; Merck Sharp & Dohme; Novartis; Pfizer; Roche Canada; Takeda
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Debiopharm Group (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Turnstone Bio (Inst)
 
Quincy S. Chu
Honoraria - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; Lilly; Merck; Novartis; Pfizer; Roche; Takeda
Research Funding - AstraZeneca; Boehringer Ingelheim
 
Daniel John Renouf
Honoraria - Celgene; Ipsen; SERVIER; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; SERVIER; Shire
Research Funding - AstraZeneca (Inst); Bayer (Inst)
 
Scott Andrew Laurie
Honoraria - AstraZeneca; Boehringer Ingelheim; Pfizer
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Novartis (Inst)
Other Relationship - Pfizer
 
Daniela Purcea
Employment - Debiopharm Group
 
Elaine McWhirter
Honoraria - Merck; Novartis
Consulting or Advisory Role - Bristol-Myers Squibb; EMD Serono; Merck; Novartis
 
Diane Arndt
No Relationships to Disclose
 
Karen A. Gelmon
Consulting or Advisory Role - AstraZeneca; Merck; Novartis; Pfizer
Expert Testimony - Genentech
 
John Hilton
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; Puma Biotechnology
 
Bruno Gavillet
Employment - Debiopharm Group
Patents, Royalties, Other Intellectual Property - Debiopharm Group (Inst)
 
Peter Michael Ellis
Honoraria - Abbvie; AstraZeneca; Pfizer
Other Relationship - Mylan
 
Michael B. Sawyer
Honoraria - Baxter; Bristol-Myers Squibb; Celgene; Fresenius Kabi; Ipsen; Leo Pharma; Merck; Novartis; Nutricia; Pfizer; Sanofi; Shire; Taiho Pharmaceutical
Consulting or Advisory Role - Celgene; Immuneering; Leo Pharma; Nutricia; Pfizer; Yinuoke
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - My lab discovered that all the competitive TKIs such as sunitinib and gefitinib have additional propoerties. This additional pharmacologic prperty casuses intestinal epithelial cells to activate their chloride channels leading to a chloride secretory diar
Travel, Accommodations, Expenses - Amgen; Ipsen; Leo Pharma; Novartis Canada Pharmaceuticals Inc; Nutricia; Pfizer
 
Christian K. Kollmannsberger
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - Novartis; Pfizer
 
Natalie Andrews Wright
Research Funding - AstraZeneca (Inst)
 
Elisabeth Rouits
Employment - Debiopharm Group
Patents, Royalties, Other Intellectual Property - Debiopharm Group
 
Frank Brichory
Employment - Debiopharm Group
 
Gregoire Vuagniaux
Employment - Debiopharm Group
Stock and Other Ownership Interests - Roche
Patents, Royalties, Other Intellectual Property - Debiopharm Group (Inst)
 
Sergio A. Szyldergemajn
Employment - Debiopharm Group; Ferring (I); SERVIER (I); Tigenix
Consulting or Advisory Role - Debiopharm Group (I)
Patents, Royalties, Other Intellectual Property - Debiopharm Group (Inst)
 
Glenwood Goss
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca